This randomised controlled parallel group Phase II trial (n=80) evaluated the safety and efficacy of ketamine for mental depression.
OBJECTIVES: to determine whether S-ketamine, used as an intra-operative sedative, can alleviate depression, in the elderly, in the immediate postoperative period. To evaluate also if low doses of S-ketamine have no adverse side effects that can restrict its clinical use.